|

Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

RECRUITINGN/ASponsored by London School of Economics and Political Science
Actively Recruiting
PhaseN/A
SponsorLondon School of Economics and Political Science
Started2025-05-09
Est. completion2025-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06997185

Summary

This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults 18 years of age and older
* Adults fluent in English
* Adults residing in the United States

Exclusion Criteria:

* Participants who do not meet each of the 3 inclusion criteria

Conditions1

Cancer

Locations1 site

Harvard Medical School and Harvard Pilgrim Health Care Institute
Boston, Massachusetts, 02139
Avi Cherla617-201-1718a.j.cherla@lse.ac.uk

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.